Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 129031, 6 pages
http://dx.doi.org/10.1155/2015/129031
Research Article

Dichloroacetate Decreases Cell Health and Activates Oxidative Stress Defense Pathways in Rat Alveolar Type II Pneumocytes

Biology Department, Davidson College, Davidson, NC 28035, USA

Received 24 November 2014; Revised 13 May 2015; Accepted 17 May 2015

Academic Editor: Sunil Kumar

Copyright © 2015 Alexis Valauri-Orton et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. J. Bull, “Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate,” Environmental Health Perspectives, vol. 108, no. 2, pp. 241–259, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. IARC (International Agency for Research on Cancer), “Dichloroacetic acid,” IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 84, pp. 359–402, 2004. View at Google Scholar
  3. P. W. Stacpoole, “The dichloroacetate dilemma: environmental hazard versus therapeutic Goldmine-both or neither?” Environmental Health Perspectives, vol. 119, no. 2, pp. 155–158, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Xu and C. P. Weisel, “Inhalation exposure to haloacetic acids and haloketones during showering,” Environmental Science and Technology, vol. 37, no. 3, pp. 569–576, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Papandreou, T. Goliasova, and N. C. Denko, “Anticancer drugs that target metabolism: is dichloroacetate the new paradigm?” International Journal of Cancer, vol. 128, no. 5, pp. 1001–1008, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Granchi and F. Minutolo, “Anticancer agents that counteract tumor glycolysis,” ChemMedChem, vol. 7, no. 8, pp. 1318–1350, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Berendzen, D. W. Theriaque, J. Shuster, and P. W. Stacpoole, “Therapeutic potential of dichloroacetate for pyruvate dehydrogenase complex deficiency,” Mitochondrion, vol. 6, no. 3, pp. 126–135, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. P. W. Stacpoole, L. R. Gilbert, R. E. Neiberger et al., “Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate,” Pediatrics, vol. 121, no. 5, pp. e1223–e1228, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. P. W. Stacpoole and Y. J. Greene, “Dichloroacetate,” Diabetes Care, vol. 15, no. 6, pp. 785–791, 1992. View at Publisher · View at Google Scholar · View at Scopus
  10. P. W. Stacpoole, D. S. Kerr, C. Barnes et al., “Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children,” Pediatrics, vol. 117, no. 5, pp. 1519–1531, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Y. Y. Wong, G. S. Huggins, M. Debidda, N. C. Munshi, and I. De Vivo, “Dichloroacetate induces apoptosis in endometrial cancer cells,” Gynecologic Oncology, vol. 109, no. 3, pp. 394–402, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Bonnet, S. L. Archer, J. Allalunis-Turner et al., “A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth,” Cancer Cell, vol. 11, no. 1, pp. 37–51, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. B. M. Madhok, S. Yeluri, S. L. Perry, T. A. Hughes, and D. G. Jayne, “Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells,” British Journal of Cancer, vol. 102, no. 12, pp. 1746–1752, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. P. W. Stacpoole, G. N. Henderson, Z. Yan, R. Cornett, and M. O. James, “Pharmacokinetics, metabolism, and toxicology of dichloroacetate,” Drug Metabolism Reviews, vol. 30, no. 3, pp. 499–539, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Gonzalez-Leon, J. L. Merdink, R. J. Bull, and I. R. Schultz, “Effect of pre-treatment with dichloroacetic or trichloroacetic acid in drinking water on the pharmacokinetics of a subsequent challenge dose in B6C3F1 mice,” Chemico-Biological Interactions, vol. 123, no. 3, pp. 239–253, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. M. O. James, W. Li, Y. Gu, T. Langaee, and P. W. Stacpoole, “Dichloroacetate-dependent inactivation of GSTZ1 in human liver cytosol is modulated by physiologically important anions in a GSTZ1 haplotype-dependent manner,” Drug Metabolism Reviews, vol. 43, p. 107, 2011. View at Google Scholar
  17. W. Li, Y. Gu, M. O. James et al., “Prenatal and postnatal expression of glutathione transferase ζ1 in human liver and the roles of haplotype and subject age in determining activity with dichloroacetate,” Drug Metabolism & Disposition, vol. 40, no. 2, pp. 232–239, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Li, M. O. James, S. C. McKenzie, N. A. Calcutt, C. Liu, and P. W. Stacpoole, “Mitochondrion as a novel site of dichloroacetate biotransformation by glutathione transferase ζ1,” Journal of Pharmacology and Experimental Therapeutics, vol. 336, no. 1, pp. 87–94, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. P. W. Stacpoole, E. M. Dunbar, A. L. Shroads, B. S. Coats, and T. Langaee, “Predictability of glutathione transferase zeta 1 haplotype on kinetics of dichloroacetate in human trials,” Drug Metabolism Reviews, vol. 43, pp. 181–182, 2011. View at Google Scholar
  20. A. L. Shroads, T. Langaee, B. S. Coats et al., “Human polymorphisms in the glutathione transferase zeta 1/maleylacetoacetate isomerase gene influence the toxicokinetics of dichloroacetate,” Journal of Clinical Pharmacology, vol. 52, no. 6, pp. 837–849, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. R. J. Bull, G. A. Orner, R. S. Cheng et al., “Contribution of dichloroacetate and trichloroacetate to liver tumor induction in mice by trichloroethylene,” Toxicology and Applied Pharmacology, vol. 182, no. 1, pp. 55–65, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. S. L. Herren-Freund, M. A. Pereira, M. D. Khoury, and G. Olson, “The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver,” Toxicology and Applied Pharmacology, vol. 90, no. 2, pp. 183–189, 1987. View at Publisher · View at Google Scholar · View at Scopus
  23. E. A. Hassoun, J. Cearfoss, and J. Spildener, “Dichloroacetate- and trichloroacetate-induced oxidative stress in the hepatic tissues of mice after long-term exposure,” Journal of Applied Toxicology, vol. 30, no. 5, pp. 450–456, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. E. A. Hassoun and J. Cearfoss, “Dichloroacetate- and trichloroacetate-induced modulation of superoxide dismutase, catalase, and glutathione peroxidase activities and glutathione level in the livers of mice after subacute and subchronic exposures,” Toxicological and Environmental Chemistry, vol. 93, no. 2, pp. 332–344, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. N. A. Calcutt, V. L. Lopez, A. D. Bautista et al., “Peripheral neuropathy in rats exposed to dichloroacetate,” Journal of Neuropathology and Experimental Neurology, vol. 68, no. 9, pp. 985–993, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. A. B. DeAngelo, F. B. Daniel, J. A. Stober, and G. R. Olson, “The carcinogenicity of dichloroacetic acid in the male B6C3F1 mouse,” Fundamental and Applied Toxicology, vol. 16, no. 2, pp. 337–347, 1991. View at Publisher · View at Google Scholar · View at Scopus
  27. V. C. Moser, P. M. Phillips, K. L. McDaniel, and R. C. MacPhail, “Behavioral evaluation of the neurotoxicity produced by dichloroacetic acid in rats,” Neurotoxicology and Teratology, vol. 21, no. 6, pp. 719–731, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. E. A. Hassoun and S. Ray, “The induction of oxidative stress and cellular death by the drinking water disinfection by-products, dichloroacetate and trichloroacetate in J774.A1 cells,” Comparative Biochemistry and Physiology Part C: Toxicology and Pharmacology, vol. 135, no. 2, pp. 119–128, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. E. A. Hassoun, J. Spildener, and J. Cearfoss, “The induction of tumor necrosis factor-alpha, Superoxide anion, Myeloperoxidase, and superoxide dismutase in the peritoneal lavage cells of mice after prolonged exposure to dichloroacetate and trichloroacetate,” Journal of Biochemical and Molecular Toxicology, vol. 24, no. 2, pp. 136–144, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. E. A. Hassoun and S. Dey, “Dichloroacetate- and trichloroacetate-induced phagocytic activation and production of oxidative stress in the hepatic tissues of mice after acute exposure,” Journal of Biochemical and Molecular Toxicology, vol. 22, no. 1, pp. 27–34, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. E. A. Hassoun and J. Mehta, “Dichloroacetate-induced modulation of cellular antioxidant enzyme activities and glutathione level in the J774A.1 cells,” Journal of Applied Toxicology, vol. 28, no. 8, pp. 931–937, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Fehrenbach, “Alveolar epithelial type II cell: defender of the alveolus revisited,” Respiratory Research, vol. 2, no. 1, pp. 33–52, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. N. A. Calcutt, V. L. Lopez, A. D. Bautista et al., “Peripheral neuropathy in rats exposed to dichloroacetate,” Journal of Neuropathology & Experimental Neurology, vol. 68, no. 9, pp. 985–993, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Chalfant and K. K. Bernd, “17β-estradiol alters rat type-II alveolar cell recovery from high levels of ozone,” PLoS ONE, vol. 9, no. 3, Article ID e90530, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. M. J. Plewa, J. E. Simmons, S. D. Richardson, and E. D. Wagner, “Mammalian cell cytotoxicity and genotoxicity of the haloacetic acids, a major class of drinking water disinfection by-products,” Environmental and Molecular Mutagenesis, vol. 51, no. 8-9, pp. 871–878, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. I. Rahman, “Regulation of nuclear factor-κB, activator protein-1, and glutathione levels by tumor necrosis factor-α and dexamethasone in alveolar epithelial cells,” Biochemical Pharmacology, vol. 60, no. 8, pp. 1041–1049, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. M. O. James, R. Cornett, Z. Yan, G. N. Henderson, and P. W. Stacpoole, “Glutathione-dependent conversion to glyoxylate, a major pathway of dichloroacetate biotransformation in hepatic cytosol from humans and rats, is reduced in dichloroacetate-treated rats,” Drug Metabolism and Disposition, vol. 25, no. 11, pp. 1223–1227, 1997. View at Google Scholar · View at Scopus
  38. M. Chalfant and K. Bernd, “Detecting ozone-induced changes in cellular redox balance via GSH/GSSG-glo assay,” Promega Corporation Website, 2012, http://worldwide.promega.com/resources/pubhub/tpub_059-detecting-ozone-induced-changes-in-cellular-redox-balance-via-gsh-gssg-glo-assay/.